Adverum Biotechnologies Inc ADVM:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 4:03 PM EDT
10.00UNCH (UNCH)
Volume
2,409
Close
10.00quote price arrow up+0.21 (+2.15%)
Volume
371,815
52 week range
7.21 - 29.70
Loading...
  • Open10.11
  • Day High10.15
  • Day Low9.50
  • Prev Close9.79
  • 52 Week High29.70
  • 52 Week High Date02/08/24
  • 52 Week Low7.21
  • 52 Week Low Date05/02/23

Key Stats

  • Market Cap207.549M
  • Shares Out20.75M
  • 10 Day Average Volume0.41M
  • Dividend-
  • Dividend Yield-
  • Beta1.17
  • YTD % Change32.84

KEY STATS

  • Open10.11
  • Day High10.15
  • Day Low9.50
  • Prev Close9.79
  • 52 Week High29.70
  • 52 Week High Date02/08/24
  • 52 Week Low7.21
  • 52 Week Low Date05/02/23
  • Market Cap207.549M
  • Shares Out20.75M
  • 10 Day Average Volume0.41M
  • Dividend-
  • Dividend Yield-
  • Beta1.17
  • YTD % Change32.84

RATIOS/PROFITABILITY

  • EPS (TTM)-11.62
  • P/E (TTM)-0.86
  • Fwd P/E (NTM)-1.81
  • EBITDA (TTM)-118.147M
  • ROE (TTM)-88.43%
  • Revenue (TTM)3.60M
  • Gross Margin (TTM)-
  • Net Margin (TTM)-3,254.58%
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date05/09/2024(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Adverum Biotechnologies Inc

 

Profile

MORE
Adverum Biotechnologies, Inc. is a clinical-stage gene therapy company. The Company discovers and develops gene therapy product candidates that provides durable efficacy by inducing sustained expression of a therapeutic protein. Its lead product candidate, ixoberogene soroparvovec (Ixo-vec), is a single, in-office intravitreal (IVT) injection gene therapy product designed to deliver long-term durable levels of aflibercept associated with a sustained treatment response...
Patrick Machado J.D.
Independent Chairman of the Board
Laurent Fischer M.D.
President, Chief Executive Officer, Director
Kishor Soparkar J.D.
Chief Operating Officer
Linda Rubinstein
Chief Financial Officer
Andrew Ramelmeier Ph.D.
Chief Technology Officer
John Rakow
General Counsel
Address
100 Cardinal Way
Redwood City, CA
94063
United States

Top Peers

SYMBOLLASTCHG%CHG
PGEN
Precigen Inc
1.40UNCHUNCH
AURA
Aura Biosciences Inc
7.77+0.12+1.57%
CRBP
Corbus Pharmaceuticals Holdings Inc
38.20+0.95+2.55%
SLDB
Solid Biosciences Inc
10.23+0.69+7.23%
TNYA
Tenaya Therapeutics Inc
4.62-0.06-1.28%